Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...

The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...

Harwood works with technology and business leaders to respond to rapid innovation at the intersection of science and technology. His research explores the rise of generative AI and accelerated use of ...

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...

According to Lazonick, his book “debunks the notion that the stock market is a value-creating institution”. Rather, “it is a ...

As artificial intelligence (AI) continues to develop at a rapid pace, even the most sophisticated general counsel (GC) and in-house legal teams ...

Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug ...

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).